Emily Chew is an Ophthalmologist in Bethesda, Maryland. Dr. Chew is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Cataract Removal.

Tiarnan Keenan is an Ophthalmologist in Bethesda, Maryland. Dr. Keenan is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Geographic Atrophy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Von Hippel-Lindau (VHL) Syndrome, and Cataract Removal.

Catherine Cukras is an Ophthalmologist in Bethesda, Maryland. Dr. Cukras is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinopathy Pigmentary Mental Retardation.

Janet Sunness is an Ophthalmologist in Baltimore, Maryland. Dr. Sunness is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Stargardt Macular Degeneration, Geographic Atrophy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD). Dr. Sunness is currently accepting new patients.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Allen Hu is an Ophthalmologist in Cumberland, Maryland. Dr. Hu is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Diabetic Retinopathy, and Vitrectomy.

Adam Gerstenblith is an Ophthalmologist in Hagerstown, Maryland. Dr. Gerstenblith is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Vitrectomy. Dr. Gerstenblith is currently accepting new patients.

Alisa Thavikulwat is an Ophthalmologist in Glenn Dale, Maryland. Dr. Thavikulwat is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Geographic Atrophy, Age-Related Macular Degeneration (ARMD), Von Hippel-Lindau (VHL) Syndrome, Late-Onset Retinal Degeneration, and Cataract Removal. Dr. Thavikulwat is currently accepting new patients.

David Warrow is an Ophthalmologist in Hagerstown, Maryland. Dr. Warrow is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, Retinal Detachment, and Vitrectomy. Dr. Warrow is currently accepting new patients.

Michael Elman is an Ophthalmologist in Baltimore, Maryland. Dr. Elman is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Vein Occlusion, and Vitrectomy. Dr. Elman is currently accepting new patients.

Michael Grodin is an Ophthalmologist in Lutherville, Maryland. Dr. Grodin is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Artery Occlusion. Dr. Grodin is currently accepting new patients.

Raymond Sjaarda is an Ophthalmologist in Baltimore, Maryland. Dr. Sjaarda is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Detachment, and Vitrectomy. Dr. Sjaarda is currently accepting new patients.

John Thompson is an Ophthalmologist in Baltimore, Maryland. Dr. Thompson is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Geographic Atrophy. Dr. Thompson is currently accepting new patients.

Gary Miller is an Ophthalmologist in Oakland, Maryland. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Diabetic Retinopathy. Dr. Miller is currently accepting new patients.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Advanced provider by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Advanced provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Advanced provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Prisca Diala is an Ophthalmologist in Annapolis, Maryland. Dr. Diala is rated as an Advanced provider by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Central Serous Chorioretinopathy, Dry Eye Syndrome, and Vitrectomy. Dr. Diala is currently accepting new patients.

Thomas Johnson is an Ophthalmologist in Rockville, Maryland. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Central Serous Chorioretinopathy, and Diabetic Retinopathy.

Lenard Hammer is an Ophthalmologist in Columbia, Maryland. Dr. Hammer is rated as an Advanced provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Glaucoma, and Geographic Atrophy. Dr. Hammer is currently accepting new patients.